An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Asthma |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/23/2019 |
| Start Date: | August 1, 2018 |
| End Date: | May 2021 |
Adapting, Scaling, and Spreading an Algorithmic Asthma Mobile Intervention to Promote Patient-Reported Outcomes Within Primary Care Settings
Through this study, the investigators will adapt the ASTHMAXcel mobile app and evaluate the
adapted intervention through a randomized controlled trial.
adapted intervention through a randomized controlled trial.
Through this study, the investigators will use patient and provider feedback to adapt the
ASTHMAXcel mobile intervention, and will conduct a randomized controlled trial to test the
intervention's impact on clinical and process outcomes.
ASTHMAXcel mobile intervention, and will conduct a randomized controlled trial to test the
intervention's impact on clinical and process outcomes.
Inclusion Criteria:
English-speaking individuals >18 years with:
1. persistent asthma(diagnosis made by a healthcare provider) on a daily controller
medication
2. able to give informed consent
3. Smartphone (iOS or Android) access
Exclusion Criteria:
1. use of oral corticosteroids in the 2 weeks prior to the baseline visit
2. pregnancy
3. severe psychiatric or cognitive problems that would prohibit an individual from
completing the protocol
4. patients that previously received ASTHMAXcel
We found this trial at
1
site
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
Click here to add this to my saved trials
